# Clinical Assessment of Spinal Muscular Atrophy Type II and III (SMA Europe)

> **NCT01611610** · NA · COMPLETED · sponsor: **Institut de Myologie, France** · enrollment: 4 (actual)

## Conditions studied

- Spinal Muscular Atrophy

## Interventions

- **OTHER:** Functional tests
- **OTHER:** Functional tests

## Key facts

- **NCT ID:** NCT01611610
- **Lead sponsor:** Institut de Myologie, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2014-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01611610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01611610, "Clinical Assessment of Spinal Muscular Atrophy Type II and III (SMA Europe)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01611610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*